Font Size: a A A
Keyword [muscular dystrophy]
Result: 161 - 180 | Page: 9 of 10
161. Structural and mechanical roles of spectrin repeat proteins in nucleated cells and implications on muscular dystrophy
162. The role of satellite cells in skeletal muscle revascularization: A potential factor in muscular dystrophy
163. Duchenne muscular dystrophy and extraocular muscle: A potential sparing mechanism with therapeutic implications
164. Analyses of alpha-dystrobrevin-null mice implicate Niemann-Pick C1 in muscular dystrophy
165. Transcriptional profiles in facioscapulohumeral muscular dystrophy and possible disease mechanisms
166. Epigenetics of tandem DNA repeats in FSH muscular dystrophy, the DNMT3B-deficient ICF syndrome, and ovarian epithelial tumors
167. Advances in recombinant adeno-associated virus technology and implications for the treatment of Duchenne muscular dystrophy
168. Gene Therapy for Facioscapulohumeral Muscular Dystrophy
169. Isolation of primary canine satellite cells
170. Improving stem cell-based therapy and developing a novel gene therapy approach for treating Duchenne Muscular Dystrophy (DMD)
171. Formation and control of trajectory during multijoint arm movements in Duchenne's muscular dystrophy
172. Adenoviral vectors for treatment of Duchenne muscular dystrophy
173. Structural flexibilty of the dystrophin rod domain: Implications for gene therapy of Duchenne muscular dystrophy using adeno-associated viral vectors
174. Parents' perspectives on Duchenne/Becker muscular dystrophy and specific learning disabilities: A grounded theory study
175. Tracking the pathophysiology of Duchenne muscular dystrophy (DMD) with functional proteomics
176. Contraction-induced muscle damage in dogs with golden retriever muscular dystrophy
177. Functional evaluation of the reversibility of muscular dystrophy in the mdx mouse via dystrophin restoration
178. AAV-mediated gene transfer to models of muscular dystrophy: Insights into assembly of multi-subunit membrane proteins
179. Maximal isometric strength on the kinetic communicator system for Duchenne muscular dystrophy patients
180. The Effects of Bisphosphonates on the Development of Glucocorticoid-Induced Osteoporosis in a Mouse Model of Duchenne Muscular Dystrophy
  <<First  <Prev  Next>  Last>>  Jump to